In brief: Avantogen, Novogen, Peplin, ResMed
02 September, 2005 by Staff WritersAlastair Hood has resigned as a director of Avantogen (ASX:ACU), formerly Australian Cancer Technology, citing increased corporate and travel commitments with his investment company Bluespire as the reason for his departure.
US talks blamed for Avantogen price dip
01 September, 2005 by Ruth BeranStalled negotiations relating to Avantogen's (ASX:ACU) US$3 million instalment in its $5 million bid to acquire US vaccine developer Regalen, formerly Galenica Pharmaceuticals, may have caused its share price to slide from $0.19 on August 24 to $0.14 on August 31, the company said today in response to an ASX query.
Kryocor puts IPO on hold
01 September, 2005 by Ruth BeranMelbourne-based tissue engineering group Kryocor, which planned to close its IPO on March 31 and list on the ASX on April 14, has postponed its float and is considering its options.
Ministers on hand for science industry plan launch
01 September, 2005 by Susan WilliamsonAn 'action agenda' for the Australian science industry -- encompassing 47,000 manufacturers, distributors, laboratory services providers and researchers -- was launched in Sydney yesterday by the minister for industry, tourism and resources, Ian Macfarlane.
Nanomics readies first product for market
01 September, 2005 by Helen SchullerQueensland University spin-out Nanomics BioSystems has released its first product based on its proprietary second-generation ceramic nanoparticle technology.
Revenues up, loss down for ChemGenex
30 August, 2005 by Helen SchullerMelbourne- and California-based ChemGenex Pharmaceuticals (ASX:CXS) posted revenues of AUD$4.1 million, up 13.9 per cent and has reduced its loss by 8.7 per cent to $4.7 million for the year ending 30 June 2005.
Molloy to leave Biota, remain in US
29 August, 2005 by Ruth BeranBiota Holdings' (ASX:BTA) US-based CEO Peter Molloy has decided not to renew his contract in January 2006 following the company's decision to consolidate its operations back into its Melbourne facility.
XRT secures new investors
29 August, 2005 by Helen SchullerUnlisted imaging company XRT, an investee of BioTech Capital (ASX:BTC), has secured new investment funds from a syndicate of UK investors including an undisclosed institutional group.
Norwood Abbey and AWI continue chemical mulesing program
26 August, 2005 by Ruth BeranNorwood Abbey (ASX:NAL) and Australian Wool Innovation (AWI) have signed an agreement to enter into phase II development of a non-surgical mulesing technology to prevent sheep flystrike using Norwood's needle-free injection technology.
BioDiem reports new chair, increased loss
26 August, 2005 by Ruth BeranAustralian corporate leader Hugh Morgan is the new chairman of Melbourne-based flu vaccine company BioDiem (ASX:BDM) which has reported an increased loss of AUD$4.2 million in 2004-05, up 32 per cent from the last financial year.
Why investors are the missing link to biotech's success
26 August, 2005 by Peter AndrewsScientists, industry and government are doing their bit to develop the Australian biotechnology industry, writes Peter Andrews -- so where are the investors?
CSL grants Merck licence for Iscomatrix
24 August, 2005 by Ruth BeranAustralia's biggest biotech, Melbourne's CSL (ASX:CSL) has signed a license and option agreement with Merck & Co, granting the New Jersey-based pharmaceutical company certain rights and options to use CSL's Iscomatrix adjuvant in its pipeline of investigational vaccine products.
Sales drive up CogState revenues
24 August, 2005 by Helen SchullerMelbourne-based neurodiagnostic specialist CogState (ASX:CGS) has reported revenues of AUD$1.5 million for the financial year ending June 30 2005, nearly three times more than the previous corresponding period, largely through sales to major pharmaceutical companies and research institutions.
Event to focus on funding
23 August, 2005 by Staff WritersA breakfast meeting in Sydney this Friday will explore ways in which technology-based companies can get their hands on Commonwealth and NSW government grants.
$1m up for grabs in Qld grants
22 August, 2005 by Staff WritersThe Queensland government is offering $950,000 to local entrepreneurs in its start-up scheme, double the amount offered in previous years.
